Residential Treatment for Individuals With Substance Use Disorders: Assessing the Evidence

Abstract

Residential treatment for substance use disorders shows value and merits ongoing consideration by policy makers for inclusion as a covered benefit in public and commercially funded plans. However, research with greater specificity and consistency is needed.

Relative Efficacy of Mindfulness-Based Relapse Prevention, Standard Relapse Prevention, and Treatment as Usual for Substance Use Disorders

“…Across all 3 groups, the rates of substance use and heavy drinking were much lower compared with those of other SUD treatment studies. 66–68 This finding is consistent with previous research 32 conducted in the same treatment agency, which found substance use rates below 30% at the 4-month follow-up. This may be the result of both continued participation in ongoing aftercare and urinalysis testing.…”

The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction

“…These modalities may be used as stand-alone interventions or in combination with pharmacotherapy. Psychosocial opioid addiction treatment approaches show value and are an important treatment option (63). However, research with greater specificity and consistency is needed to better evaluate outcomes.…”

Recovery Housing: Assessing the Evidence

“…Other housing models for individuals with substance use disorders that do not require total abstinence as a requirement for residence (for example, "wet houses" or "damp houses") were excluded from this review because they are associated with Housing First models. Residential treatment and therapeutic communities are covered in a review of research on residential treatment for substance use disorders in this series (9). Also excluded were articles about shelters or other housing-only options without a recovery focus.…”